glp-1 receptor agonist kidney outcomes semaglutide flow trial 2024 results Ozempic® (semaglutide injection) GLP-1 receptor agonists' impact on

What should I eat if I'm on a GLP-1 medication

The side effect comparison between the two also helps clarify their risk profiles

GLP-1 based therapies and disease course of inflammatory bowel disease

UNICEF highlights that over 340 million children and adolescents aged 519 are overweight or obese, while chronic disease burden continues rising globally, encouraging development of improved long-acting and patient-friendly drug formulations to enhance treatment adherence and long-term outcomes

Side effects Commonly reported side effects include: Nausea Constipation Diarrhea Vomiting Stomach (abdominal) pain Indigestion Headache Other potential side effects: Fatigue Belching Heartburn Bloating Hair loss Decreased appetite Gastroesophageal reflux disease Injection site reactions Most GI side effects are more common in the first few weeks and tend to ease as your body adjusts

Standard Part D plans may still cover GLP-1s when prescribed for other FDA-approved uses, like type 2 diabetes, obstructive sleep apnea, or cardiovascular risk reduction in people with overweight or obesity